Literature DB >> 24057236

Tumor suppressor ING4 overexpression contributes to proliferation and invasion inhibition in gastric carcinoma by suppressing the NF-κB signaling pathway.

Shijie Li1, Tianli Fan, Hongtao Liu, Jiangtao Chen, Changjiang Qin, Xuequn Ren.   

Abstract

There is growing evidence that inhibitor of growth 4 (ING4) plays a pivotal role in development and progression of multiple different tumors; however, its precise function in gastric carcinoma remains to be elucidated. In the present study, we investigated ING4 level in gastric carcinoma tissues and cells, and preliminarily elucidated the role of ING4 in the proliferation and invasion of gastric carcinoma. The results demonstrated that expressions of ING4 mRNA and protein in gastric carcinoma tissues and cells were significantly lower than those in normal tissues and cells (P < 0.05). ING4 level in gastric carcinoma cells stably expressing ING4 was markedly higher than those in untreated group and empty vector pcDNA3.1 group (P < 0.05). Elevated ING4 level resulted in the inhibition of proliferation and invasion in three of gastric carcinoma cell lines MKN-28, SGC-7901 and MKN-45. Most notably, increased ING4 level evidently evoked the down-regulation of p65, p-IκBα, MMP-9 and uPA proteins and the up-regulation of IκBα protein. Our results presented herein suggest that ING4 level elevation mediated proliferation and invasion inhibition may be tightly associated with the suppression of NF-κB signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24057236     DOI: 10.1007/s11033-013-2675-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  45 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer.

Authors:  Shishir Shishodia; Bharat B Aggarwal
Journal:  Cancer Treat Res       Date:  2004

3.  An activated Notch1 signaling pathway inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma cell line EC9706.

Authors:  Zhaoming Lu; Hongtao Liu; Lexun Xue; Peirong Xu; Tianxiao Gong; Guiqin Hou
Journal:  Int J Oncol       Date:  2008-03       Impact factor: 5.650

4.  Genetic and epigenetic alterations in multistep carcinogenesis of the stomach.

Authors:  W Yasui; H Yokozaki; J Fujimoto; K Naka; H Kuniyasu; E Tahara
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

5.  Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma.

Authors:  Xiao-han Li; Keiji Kikuchi; Yang Zheng; Akira Noguchi; Hiroyuki Takahashi; Takeshi Nishida; Shinji Masuda; Xiang-hong Yang; Yasuo Takano
Journal:  Oral Oncol       Date:  2011-03       Impact factor: 5.337

6.  RelA, p50 and inhibitor of kappa B alpha are elevated in human metastatic melanoma cells and respond aberrantly to ultraviolet light B.

Authors:  S E McNulty; N B Tohidian; F L Meyskens
Journal:  Pigment Cell Res       Date:  2001-12

7.  Down-regulation of ING4 is associated with initiation and progression of lung cancer.

Authors:  Qiu-shi Wang; Ming Li; Lin-you Zhang; Yan Jin; Dan-dan Tong; Yang Yu; Jing Bai; Qi Huang; Fang-Li Liu; An Liu; Ki-Young Lee; Song-bin Fu
Journal:  Histopathology       Date:  2010-08       Impact factor: 5.087

8.  Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.

Authors:  Feng Fang; Lai-Bang Luo; Yi-Ming Tao; Fan Wu; Lian-Yue Yang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02       Impact factor: 4.254

9.  Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy.

Authors:  C Ling; Y Xie; D Zhao; Y Zhu; J Xiang; J Yang
Journal:  Cancer Gene Ther       Date:  2012-08-03       Impact factor: 5.987

10.  Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance.

Authors:  Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2009-10-20       Impact factor: 5.344

View more
  10 in total

1.  Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy.

Authors:  Aymen Shatnawi; Sridhar A Malkaram; Tamer Fandy; Efrosini Tsouko
Journal:  Mol Cell Biochem       Date:  2019-11-27       Impact factor: 3.396

Review 2.  INGs are potential drug targets for cancer.

Authors:  Runyun Zhang; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-20       Impact factor: 4.553

Review 3.  Inhibitor of growth-4 is a potential target for cancer therapy.

Authors:  Shuping Yuan; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  Tumour Biol       Date:  2016-01-23

4.  Reduced expression and prognostic implication of inhibitor of growth 4 in human osteosarcoma.

Authors:  Dahang Zhao; Xiangjie Liu; Yunge Zhang; Zhaoming Ding; Feng Dong; Hongwei Xu; Baoxin Wang; Wenbo Wang
Journal:  Oncol Lett       Date:  2016-03-09       Impact factor: 2.967

Review 5.  NF-κB Signaling in Gastric Cancer.

Authors:  Olga Sokolova; Michael Naumann
Journal:  Toxins (Basel)       Date:  2017-03-28       Impact factor: 4.546

6.  miR-650 promotes non-small cell lung cancer cell proliferation and invasion by targeting ING4 through Wnt-1/β-catenin pathway.

Authors:  Xiangqin Tang; Yanjun Ding; Xiaoqing Wang; Xiuzhen Wang; Lin Zhao; Hongmei Bi
Journal:  Oncol Lett       Date:  2019-09-04       Impact factor: 2.967

7.  Delivery of inhibitor of growth 4 (ING4) gene significantly inhibits proliferation and invasion and promotes apoptosis of human osteosarcoma cells.

Authors:  Mei Li; Ye Zhu; Hongbin Zhang; Lihua Li; Peng He; Hong Xia; Yu Zhang; Chuanbin Mao
Journal:  Sci Rep       Date:  2014-12-09       Impact factor: 4.379

8.  miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis.

Authors:  Tingting Huang; Wei Kang; Bin Zhang; Feng Wu; Yujuan Dong; Joanna H M Tong; Weiqin Yang; Yuhang Zhou; Li Zhang; Alfred S L Cheng; Jun Yu; Ka Fai To
Journal:  Mol Cancer       Date:  2016-01-22       Impact factor: 27.401

9.  MicroRNA-650 targets inhibitor of growth 4 to promote colorectal cancer progression via mitogen activated protein kinase signaling.

Authors:  Qi You; Huining Li; Yao Liu; Yangyang Xu; Susheng Miao; Guodong Yao; Yingwei Xue; Jingshu Geng; Xiaoming Jin; Hongxue Meng
Journal:  Oncol Lett       Date:  2018-06-06       Impact factor: 2.967

Review 10.  The essential role of tumor suppressor gene ING4 in various human cancers and non-neoplastic disorders.

Authors:  Yang Du; Yan Cheng; Guanfang Su
Journal:  Biosci Rep       Date:  2019-01-30       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.